Literature DB >> 15480162

Effect of brain death on gene expression and tissue activation in human donor kidneys.

Willemijn N Nijboer1, Theo A Schuurs, Joost A B van der Hoeven, Susan Fekken, Janneke Wiersema-Buist, Henri G D Leuvenink, Sijbrand Hofker, Jaap J Homan van der Heide, Willem J van Son, Rutger J Ploeg.   

Abstract

BACKGROUND: After kidney transplantation, decreased graft survival is seen in grafts from brain dead (BD) donors compared with living donors. This might result partly from a progressive nonspecific inflammation in the graft. In this study, we focused on the effects of BD on inflammatory response (adhesion molecules, leukocyte invasion, gene expression) and stress-related heat shock proteins in the human kidney. Research outcomes and clinical donor parameters were then linked to outcome data after transplantation.
METHODS: Kidney biopsy specimens and serum were obtained during organ retrieval from BD and living organ donor controls. Immunohistochemistry and semiquantitative reverse transcriptase-polymerase chain reaction were performed on the biopsy specimens. Clinical and laboratory parameters from BD donors were recorded and connected to outcome data of the recipients of the kidneys studied.
RESULTS: After brain death, immunohistochemistry showed an increase of E-selectin (P<0.01) and interstitial leukocyte invasion (P<0.05) compared with controls. Also, reverse transcriptase-polymerase chain reaction showed a threefold increased heme oxygenase-1 (P<0.05) and Hsp70 (P<0.01) gene expression after BD. Levels of monocyte chemotactic protein-1 and transforming growth factor-beta were twice as high after brain death but did not reach significance. Transplantation outcome was influenced by several donor variables: positively most notably by donor treatment with desmopressin and negatively by high serum urea levels during brain death and by high intercellular adhesion molecule and vascular cell adhesion molecule expression in the kidney. Heme oxygenase-1 proved to have a protective function, but only in kidneys from living donors.
CONCLUSIONS: The presence of interstitial leukocytes and the early adhesion molecule E-selectin in BD donor kidneys indicates an early-phase inflammatory process during organ retrieval. Elevated levels of monocyte chemotactic protein-1 and transforming growth factor-beta suggest a role for monocytes/macrophages in this phase. We suggest that BD causes a stress-related response against which protective heat shock proteins are formed in the future graft. This stress response may be too severe to be fully counteracted by elevated heat shock proteins. Which systemic and/or local factors trigger brain death-related graft injury is currently under investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15480162     DOI: 10.1097/01.tp.0000135565.49535.60

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  29 in total

1.  Effect of donor JNK signal transduction inhibition on transplant outcome in brain dead rat model.

Authors:  Lu Chen; Danfeng Xu; Yi Gao; Xingang Cui; Zunguo Du; Qiang Ding; Xiang Wang
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

Review 2.  Assessment of kidney organ quality and prediction of outcome at time of transplantation.

Authors:  Thomas F Mueller; Kim Solez; Valeria Mas
Journal:  Semin Immunopathol       Date:  2011-01-28       Impact factor: 9.623

3.  Brain Death Enhances Activation of the Innate Immune System and Leads to Reduced Renal Metabolic Gene Expression.

Authors:  Laura J Zitur; Peter J Chlebeck; Scott K Odorico; Juan S Danobeitia; Tiffany J Zens; Cees Van Kooten; Michael Eerhart; Jose A Reyes; Megan L Springer; Jennifer M Coonen; Kevin G Brunner; Saverio V Capuano; Anthony M D'Alessandro; Luis A Fernandez
Journal:  Transplantation       Date:  2019-09       Impact factor: 4.939

4.  S100B protein may detect brain death development after severe traumatic brain injury.

Authors:  Juan J Egea-Guerrero; Francisco Murillo-Cabezas; Elena Gordillo-Escobar; Ana Rodríguez-Rodríguez; Judy Enamorado-Enamorado; Jaume Revuelto-Rey; María Pacheco-Sánchez; Antonio León-Justel; Jose M Domínguez-Roldán; Angel Vilches-Arenas
Journal:  J Neurotrauma       Date:  2013-08-28       Impact factor: 5.269

Review 5.  The role of innate immunity in donor organ procurement.

Authors:  Dianne B McKay
Journal:  Semin Immunopathol       Date:  2011-03-23       Impact factor: 9.623

6.  Tubular expression of KIM-1 does not predict delayed function after transplantation.

Authors:  Bernd Schröppel; Bernd Krüger; Liron Walsh; Melissa Yeung; Shay Harris; Krista Garrison; Jonathan Himmelfarb; Susan M Lerner; Jonathan S Bromberg; Ping L Zhang; Joseph V Bonventre; Zhu Wang; Alton B Farris; Robert B Colvin; Barbara T Murphy; John P Vella
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

7.  Brain dead donor kidneys are immunologically active: is intervention justified?

Authors:  G Vergoulas; P Boura; G Efstathiadis
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

8.  Repletion of S-nitrosohemoglobin improves organ function and physiological status in swine after brain death.

Authors:  Basil M Yurcisin; Tara E Davison; Syreena M Bibbs; Bradley H Collins; Jonathan S Stamler; James D Reynolds
Journal:  Ann Surg       Date:  2013-05       Impact factor: 12.969

9.  Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients.

Authors:  Jayme E Locke; Daniel S Warren; Francesca Dominici; Andrew M Cameron; M Sue Leffell; Deborah A McRann; J Keith Melancon; Dorry L Segev; Christopher E Simpkins; Andrew L Singer; Andrea A Zachary; Robert A Montgomery
Journal:  J Am Soc Nephrol       Date:  2008-07-23       Impact factor: 10.121

10.  Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation.

Authors:  W N Nijboer; T A Schuurs; J Damman; H van Goor; V S Vaidya; J J Homan van der Heide; H G D Leuvenink; J V Bonventre; R J Ploeg
Journal:  Am J Transplant       Date:  2009-06-12       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.